Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns.
Saved in:
| Title: | Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. |
|---|---|
| Authors: | Quatannens D; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Verhoeven Y; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., van der Heijden S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Peeters D; Department of Pathology, Antwerp University Hospital (UZA), Antwerp, Belgium., Claes J; Data Science Institute, I-Biostat, Hasselt University, Hasselt, Belgium., Hermans C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Zwaenepoel K; Department of Pathology, Antwerp University Hospital (UZA), Antwerp, Belgium., van Dam P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium., Peeters M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Prenen H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital (UZA), Antwerp, Belgium., Koljenovic S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Pathology, Antwerp University Hospital (UZA), Antwerp, Belgium., De Waele J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Faes C; Data Science Institute, I-Biostat, Hasselt University, Hasselt, Belgium., Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Roeyen G; Department of Hepatobiliary Transplantation and Endocrine Surgery, Antwerp University Hospital (UZA), Antwerp, Belgium., Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium., Van Audenaerde J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium. jonas.vanaudenaerde@uantwerpen.be. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 10; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
